| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |